Waterlily Pharmaceuticals

Founded 2017

Overview

Start up company focus on the research and development for hypoxia-target cancer diagnosis and treatment.

Management Team

Manager

Xiaoshen Ji

Working on hypoxia-target PET and MRI imaging agents for tumor diagnosis and hypoxia-target prodrugs for cancer therapy. Designed and synthesized series of 2-nitroimidazole derivative and F, Cu and Gd compounds for above use.